Sort
53,477 grants matching “addiction”
Drug Abuse and Related Health Disparities: An Intergenerational Longitudinal Study of Offspring of Delinquent Youth (Northwestern Offspring Project)
$631,540Linda A Teplin · Northwestern University At Chicago · R01 · FY2018 · DA
Regulation of Craving Under Stress: Neural Mechanisms and Novel Model
$631,540Hedy Kober · Yale University · R01 · FY2018 · DA
Twin Family Study of Vulnerability to Substance Abuse
$631,504William G Iacono · University Of Minnesota · R37 · FY2014 · DA
TRAINING IN NEUROIMMUNE/NEUROBEHAVIOR ADDICTION RESEARCH
$631,431Thomas William Molitor · University Of Minnesota · T32 · FY2007 · DA
Long acting biodegradable buprenorphine depots
$631,404Andrew Otte · Purdue University · UG3 · FY2023 · DA
Seek and Treat for Optimal Prevention of HIV & AIDS (STOP HIV/AIDS) in BC
$631,379Julio Sergio Gonzalez Montaner · University Of British Columbia · R01 · FY2016 · DA
Middle School Cluster RCT to Evaluate E-Cigarette Prevention Program: CATCH My Breath
$631,366Steven H Kelder · University Of Texas Hlth Sci Ctr Houston · R01 · FY2021 · CA
Optogenetic Tools for in vivo Analysis of Cortical Circuit Plasticity
$631,304Peter Saggau · Baylor College Of Medicine · R01 · FY2009 · DA
Long-acting naltrexone for pre-release prisoners: A randomized trial of mobile treatment
$631,303Michael Scott Gordon · Friends Research Institute, Inc. · R01 · FY2017 · DA
HIV, HCV and Liver Disease Among Injection Drug Users in Chennai, India
$631,218Shruti H Mehta · Johns Hopkins University · R01 · FY2010 · DA
Signal Transduction by Tyrosine Phosphorylation
$631,180Tony R. Hunter · Salk Institute For Biological Studies · R01 · FY2013 · CA
Training in Neuroimmune/Neurobehavior Addiction Research
$631,161Thomas William Molitor · University Of Minnesota · T32 · FY2016 · DA
Development of Hsp90 Isoform- Selective Inhibitors as a Novel Opioid Dose-Reduction Therapy
$631,104John Michael Streicher · University Of Arizona · R01 · FY2022 · DA
Development of Hsp90 Isoform- Selective Inhibitors as a Novel Opioid Dose-Reduction Therapy
$631,104John Michael Streicher · University Of Arizona · R01 · FY2023 · DA
Development of Hsp90 Isoform- Selective Inhibitors as a Novel Opioid Dose-Reduction Therapy
$631,104John Michael Streicher · University Of Arizona · R01 · FY2025 · DA
Development of Hsp90 Isoform- Selective Inhibitors as a Novel Opioid Dose-Reduction Therapy
$631,104John Michael Streicher · University Of Arizona · R01 · FY2024 · DA
Test of a Workforce Development Intervention to Expand Buprenorphine Prescribers
$631,016Todd David Molfenter · University Of Wisconsin-Madison · R01 · FY2016 · DA
Targeting dopamine D3 receptors in cocaine addiction
$630,901Anna Rose Childress · University Of Pennsylvania · R01 · FY2017 · DA
Drug Abuse Trajectories in the Transition to Adulthood: Risk Factors and Outcomes
$630,757Amelia M Arria · Univ Of Maryland, College Park · R01 · FY2012 · DA
Functional and Genomic Signatures of Escalated Fentanyl Use
$630,736Jill R. Turner · University Of Kentucky · R01 · FY2021 · DA
Research Education Core
$630,715Danielle Sheldon Rudes · George Mason University · U2C · FY2024 · DA
Practice Facilitation to Promote Evidence-based Screening and Management of Unhealthy Alcohol Use in Primary Care
$630,690Alexander H Krist · Virginia Commonwealth University · R18 · FY2021 · HS
Investigation of the role of epithelial-mesenchymal plasticity in renal cell carcinoma
$630,665Giannicola Genovese · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Juvenile Offender HIV Prevention and Drug Abuse Services
$630,548Howard A Liddle · University Of Miami School Of Medicine · R01 · FY2012 · DA
Chemical biology of Peptide Regulation of Opioid Receptor Function
$630,544Carrie Haskell-Luevano · University Of Minnesota · R01 · FY2023 · DA